CIK: 0001372218
Total reported value
$37.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RETAEUR | Reata Pharmaceuticals Inc-a | Stock-Other | 67.78% | — | — | |
| 2 | ✓ | Instil Bio, Inc. | Stock-Other | 27.08% | — | — | |
| 3 | HQ8F | Apollo Endosurgery INC | Stock-Other | 4.24% | — | — | |
| 4 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 0.89% | — | +23.74% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RETAEUR | Reata Pharmaceuticals Inc-a | +12.5% | — | Unchanged |
| 2 | HQ8F | Apollo Endosurgery INC | +0.9% | — | Unchanged |
| 3 | QQQ | Invesco Qqq Trust Series 1 | +0.1% | +23.74% | Add |
| 4 | ✓ | Instil Bio, Inc. | -13.6% | — | Unchanged |